{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T02:39:47Z","timestamp":1778294387662,"version":"3.51.4"},"reference-count":30,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:00:00Z","timestamp":1773964800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Portuguesa de Cardiologia"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.repc.2025.11.011","type":"journal-article","created":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T16:26:05Z","timestamp":1774110365000},"page":"231-238","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Management of lipid profile and lipid-lowering therapy in the diabetic population of a primary care center according to cardiovascular risk category (SCORE2-Diabetes vs. SCORE)"],"prefix":"10.1016","volume":"45","author":[{"given":"Andr\u00e9","family":"Cunha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo\u00e3o","family":"Pedro Correia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joana","family":"Calheiros Lobo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisca","family":"Botelho Elias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro","family":"Costa Leite","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catarina","family":"Braz\u00e3o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Lucas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dinis","family":"B. Loyens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.repc.2025.11.011_bib0155","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1016\/j.jacc.2023.11.007","article-title":"Global burden of cardiovascular diseases and risks, 1990\u20132022","volume":"82","author":"Mensah","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.repc.2025.11.011_bib0160","series-title":"Em 2022, aumentaram principalmente as mortes por doen\u00e7as do aparelho respirat\u00f3rio","year":"2024"},{"key":"10.1016\/j.repc.2025.11.011_bib0165","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.repc.2020.08.007","article-title":"Atherosclerosis: the cost of illness in Portugal","volume":"40","author":"Costa","year":"2021","journal-title":"Rev Port Cardiol (Engl Ed)"},{"key":"10.1016\/j.repc.2025.11.011_bib0170","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1016\/S0140-6736(10)60484-9","article-title":"Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies","volume":"375","author":"Sarwar","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.repc.2025.11.011_bib0175","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1161\/CIRCULATIONAHA.118.037885","article-title":"Age at diagnosis of type 2 diabetes mellitus and associations with cardiovascular and mortality risks","volume":"139","author":"Sattar","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.repc.2025.11.011_bib0180","series-title":"Norma no. 005\/2013 de 19\/03\/2013, atualizada a 21\/01\/2015 Avalia\u00e7\u00e3o do risco cardiovascular \u2013 SCORE (Systematic Coronary Risk Evaluation) [Internet]","year":"2015"},{"key":"10.1016\/j.repc.2025.11.011_bib0185","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S0195-668X(03)00114-3","article-title":"Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project","volume":"24","author":"Conroy","year":"2003","journal-title":"Eur Heart J"},{"key":"10.1016\/j.repc.2025.11.011_bib0190","series-title":"Norma no. 005\/2013 de 19\/03\/2013, atualizada a 10\/04\/2025. Avalia\u00e7\u00e3o do risco cardiovascular [Internet]","year":"2025"},{"key":"10.1016\/j.repc.2025.11.011_bib0195","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1093\/eurheartj\/ehad192","article-title":"2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes","volume":"44","author":"Marx","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.repc.2025.11.011_bib0200","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1093\/eurheartj\/ehad260","article-title":"SCORE2-Diabetes: 10-year cardiovascular risk estimation in type 2 diabetes in Europe","volume":"44","author":"SCORE2-Diabetes Working Group","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.repc.2025.11.011_bib0205","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1093\/eurheartj\/ehx144","article-title":"Low-density lipoproteins cause atherosclerotic cardiovascular disease 1. Evidence from genetic, epidemiologic, and clinical studies","volume":"38","author":"Ference","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.repc.2025.11.011_bib0210","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1016\/j.jacc.2012.09.017","article-title":"Effect of long-term exposure to lower low-density lipoprotein cholesterol beginning early in life on the risk of coronary heart disease: a Mendelian randomization analysis","volume":"60","author":"Ference","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.repc.2025.11.011_bib0215","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk","volume":"41","author":"Mach","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.repc.2025.11.011_bib0220","series-title":"Dados de consumos de medicamentos no mercado do Servi\u00e7o Nacional de Sa\u00fade","year":"2017"},{"key":"10.1016\/j.repc.2025.11.011_bib0225","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1016\/j.jacc.2013.11.002","article-title":"2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults","volume":"63","author":"Stone","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.repc.2025.11.011_bib0230","doi-asserted-by":"crossref","first-page":"6825","DOI":"10.3390\/jcm11226825","article-title":"Cardiovascular risk profile and lipid management in the population-based cohort study LATINO: 20 years of real-world data","volume":"11","author":"Gavina","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.repc.2025.11.011_bib0235","doi-asserted-by":"crossref","first-page":"213","DOI":"10.4093\/dmj.2020.0001","article-title":"Fibrates revisited: potential role in cardiovascular risk reduction","volume":"44","author":"Kim","year":"2020","journal-title":"Diabetes Metab J"},{"key":"10.1016\/j.repc.2025.11.011_bib0240","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.3390\/jpm12091402","article-title":"Pharmacogenetics of cardiovascular prevention in diabetes: from precision medicine to identification of novel targets","volume":"12","author":"Morieri","year":"2022","journal-title":"J Pers Med"},{"key":"10.1016\/j.repc.2025.11.011_bib0245","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1093\/eurheartj\/ehab309","article-title":"SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe","volume":"42","author":"SCORE2 Working Group","year":"2021","journal-title":"Eur Heart J"},{"issue":"Suppl. 1","key":"10.1016\/j.repc.2025.11.011_bib0250","first-page":"S179","article-title":"10. Cardiovascular disease and risk management: standards of care in diabetes \u2013 2024","volume":"47","year":"2024","journal-title":"Diabetes Care"},{"key":"10.1016\/j.repc.2025.11.011_bib0255","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0140-6736(05)67667-2","article-title":"Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study)","volume":"366","author":"Keech","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.repc.2025.11.011_bib0260","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1056\/NEJMoa1001282","article-title":"Effects of combination lipid therapy in type 2 diabetes mellitus","volume":"362","author":"Ginsberg","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.repc.2025.11.011_bib0265","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ahj.2018.09.011","article-title":"Rationale and design of the pemafibrate to reduce cardiovascular outcomes by reducing triglycerides in patients with diabetes (PROMINENT) study","volume":"206","author":"Pradhan","year":"2018","journal-title":"Am Heart J"},{"issue":"Suppl_1","key":"10.1016\/j.repc.2025.11.011_bib0270","article-title":"Differences in 10-year cardiovascular risk estimation using SCORE and SCORE2 risk prediction tools: a moderate risk country population analysis","volume":"30","author":"Quintal","year":"2023","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.repc.2025.11.011_bib0275","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.repc.2023.10.012","article-title":"Cardiovascular risk assessment in Portugal's primary health care system: SCORE vs. SCORE2","volume":"43","author":"Silva","year":"2024","journal-title":"Rev Port Cardiol"},{"key":"10.1016\/j.repc.2025.11.011_bib0280","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.repc.2023.10.011","article-title":"Validation of the SCORE2 risk prediction algorithm in a Portuguese population: a new model to estimate 10-year cardiovascular disease incidence in Europe","volume":"43","author":"Temtem","year":"2024","journal-title":"Rev Port Cardiol"},{"issue":"Suppl_1","key":"10.1016\/j.repc.2025.11.011_bib0285","article-title":"Comparison of SCORE and SCORE 2 model for cardiovascular risk stratification in men and women from high risk European country","volume":"30","author":"Giga","year":"2023","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.repc.2025.11.011_bib0290","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2022-002087","article-title":"Differences of cardiovascular risk assessment in clinical practice using SCORE and SCORE2","volume":"9","author":"Csenteri","year":"2022","journal-title":"Open Heart"},{"issue":"Suppl_2","key":"10.1016\/j.repc.2025.11.011_bib0295","article-title":"Comparison of SCORE and SCORE 2 risk prediction tools in contemporary very high risk European population","volume":"43","author":"Boskovic","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.repc.2025.11.011_bib0300","doi-asserted-by":"crossref","DOI":"10.15829\/1560-4071-2022-5006","article-title":"Appointment of lipid-lowering therapy in the Russian population: comparison of SCORE and SCORE2 (according to the ESSE-RF study)","volume":"27","author":"Erina","year":"2022","journal-title":"Russ J Cardiol"}],"container-title":["Revista Portuguesa de Cardiologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0870255126000855?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0870255126000855?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T13:26:30Z","timestamp":1778246790000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0870255126000855"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S0870255126000855"],"URL":"https:\/\/doi.org\/10.1016\/j.repc.2025.11.011","relation":{},"ISSN":["0870-2551"],"issn-type":[{"value":"0870-2551","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of lipid profile and lipid-lowering therapy in the diabetic population of a primary care center according to cardiovascular risk category (SCORE2-Diabetes vs. SCORE)","name":"articletitle","label":"Article Title"},{"value":"Revista Portuguesa de Cardiologia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.repc.2025.11.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Sociedade Portuguesa de Cardiologia. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}